Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level ≥50 ng/mL-Reference-Cited by-同舟云学术

Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level ≥50 ng/mL

Published:2008-10-01 Issue:7 Volume:113 Page:1544-1551
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Inman Brant A.,Davies Judson D.,Rangel Laureano J.,Bergstralh Eric J.,Kwon Eugene D.,Blute Michael L.,Karnes R. Jeffrey,Leibovich Bradley C.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference26 articles.

1. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005;Makarov;Urology.,2007

2. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer;Grossfeld;J Urol.,2003

3. Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma;Hugosson;Cancer.,2004

4. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE);Meng;J Urol.,2005

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Pre-Operative Total Prostate-Specific Antigen and Survivorship of Prostate Cancer following Radical Prostatectomy: A Systematic Review;Medical Principles and Practice;2023-12-22

2. Very Long‐Term Complete Remission Can Be Achieved in Men With High‐Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial;Clinical Genitourinary Cancer;2023-10

3. Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate‐specific antigen concentrations;The Prostate;2023-08-07

4. Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions;American Society of Clinical Oncology Educational Book;2020-05

5. Resultados oncológicos a largo plazo del tratamiento cáncer de próstata de alto riesgo mediante prostatectomía radical en un hospital oncológico;Actas Urológicas Españolas;2018-10